Azora Therapeutics Quarterly Income Statement
NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.85-0.02 (-0.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Azora Therapeutics revenue and earnings
Azora Therapeutics reported a net loss of $64.6 million, compared with a loss of $1.8 million a year earlier. Diluted earnings per share came in at -$4.52.
Summary generated from market data by MetaCap's automated system. Methodology
Azora Therapeutics income statement (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q2 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 7.53M | 52.02M | 2.00M | 1.89M | 1.76M | 1.88M | 2.27M | 1.94M | 2.21M | 2.29M | 1.85M | 1.78M |
| Research & Development | 1.77M | 440.00K | 432.53K | 619.67K | 521.00K | 732.00K | 746.89K | 730.79K | 1.03M | 1.01M | 454.28K | 264.44K |
| Operating Income | -7.53M | -52.02M | -2.00M | -1.89M | -1.76M | -1.88M | -2.27M | -1.94M | -2.21M | -2.29M | -1.85M | -1.78M |
| Other Income (Expense) | -57.03M | 36.00K | -20.91K | -110.71K | -30.00K | -76.00K | 38.49K | -130.06K | 19.67K | -171.07K | -4.63M | -120.60K |
| Pretax Income | — | — | — | — | — | — | — | -2.07M | -2.19M | -2.46M | — | -1.90M |
| Net Income | -64.56M | -51.99M | -2.02M | -2.00M | -1.79M | -1.96M | -2.23M | -2.07M | -2.19M | -2.46M | -6.48M | -1.92M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | -325.99% | — | — |
| EPS (Basic) | -4.52 | -11.25 | -1.48 | 3.22 | -2.02 | -4.61 | -8.52 | -64.85 | -0.38 | -0.59 | -2.19 | -3.27 |
| EPS (Diluted) | -4.52 | -11.25 | -1.48 | 3.22 | -2.02 | -4.61 | -8.52 | -64.85 | -0.38 | -0.59 | -2.19 | -3.27 |
| Shares Outstanding (Basic) | 14.30M | 4.62M | 1.37M | — | 886.85K | 424.91K | 261.59K | — | 5.84M | — | — | — |
| Shares Outstanding (Diluted) | 14.30M | 4.62M | 1.37M | — | 886.85K | 424.91K | 261.59K | — | 5.84M | 4.18M | 2.95M | — |
This table shows 12 quarterly periods of Azora Therapeutics's income statement, from Q3 2026 back to Q4 2023, across 11 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a income statement?